Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second Opinion: Looking into the study presented at AAOS 2025 recommending discontinuation of GLP-1 agonists prior to surgery to prevent anesthesia complications.

Ticker(s): NVO, LLY

Who's the expert?

Institution: WVU Medicine

Orthopedic sports medicine specialist and Director of WVU Reynolds Orthopedic Surgeons.
Performs 10-15 bone grafting procedures annually.
Comfortable discussing the FDA approval of OsteoFlo HydroPutty and how it might compare with current bone graft technology.

Interview Goal

Topic: to discuss the current protocols for pre-operative care and the recent study presented at AAOS 2025 recommending discontinuation of GLP-1 agonists prior to surgery to prevent anesthesia complications.

Do you want answers to these questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.